Pharmacist-managed international normalized ratio patient self-testing is associated with increased time in therapeutic range in patients with left ventricular assist devices at an academic medical center

ASAIO Journal

Volumn 60, Issue 2, 2014, Pages 193-198

  Bishop, Martin A ^a   Streiff, Michael B ^b   Ensor, Christopher R ^c   Tedford, Ryan J ^b   Russell, Stuart D ^b   Ross, Patricia A ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Anticoagulation; INR; Left ventricular assist device; LVAD; Patient self testing

Indexed keywords

LEFT VENTRICULAR ASSIST DEVICES;

ACADEMIC MEDICAL CENTERS; ANTI-COAGULATION; DEMOGRAPHIC DATA; INR; INTERNATIONAL NORMALIZED RATIOS; LVAD; SELF-TESTING; THERAPEUTIC RANGE;

PATIENT TREATMENT;

WARFARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLEEDING; FEMALE; HUMAN; INTERMETHOD COMPARISON; INTERNATIONAL NORMALIZED RATIO; LEFT VENTRICULAR ASSIST DEVICE; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE; MIDDLE AGED; PHARMACIST; POINT OF CARE TESTING; PRIORITY JOURNAL; SELF EVALUATION;

ACADEMIC MEDICAL CENTERS; ANTICOAGULANTS; COHORT STUDIES; DRUG MONITORING; FEMALE; HEART-ASSIST DEVICES; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; PHARMACISTS; POINT-OF-CARE SYSTEMS; RETROSPECTIVE STUDIES; SELF CARE; WARFARIN;

EID: 84896386437     PISSN: 10582916     EISSN: 1538943X     Source Type: Journal    
DOI: 10.1097/MAT.0000000000000047     Document Type: Article

References (32)

1. Go AS, Mozaffarian D, Roger VL, et al: Heart disease and stroke statistics - 2013 update. A report from the American Heart Association. Circulation 127: e6-e245, 2013.
2. U.S. Department of Health & Human Services: Health resources and services administration: OPTN/SRTR 2011 annual report. Figure 3.1: Total adult heart transplants. Available at: http://srtr. transplant.hrsa.gov/annual- reports/2011/pdf/05-heart-12.pdf. Updated December 2013.
3. Kilic A, Ailawadi G: Left ventricular assist devices in heart failure. Expert Rev Cardiovasc Ther 10: 649-656, 2012.
4. Elhenawy AM, Algarni KD, Rodger M, et al: Mechanical circulatory support as a bridge to transplant candidacy. J Card Surg 26: 542-547, 2011.
5. Demirozu ZT, Radovancevic R, Hochman LF, et al: Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device. J Heart Lung Transplant 30: 849-853, 2011.
6. Frazier OH, Delgado RM III, Kar B, Patel V, Gregoric ID, Myers TJ: First clinical use of the redesigned HeartMate II left ventricular assist system in the United States: A case report. Tex Heart Inst J 31: 157-159, 2004. (Pubitemid 38747887)
7. Amir O, Bracey AW, Smart FW, Delgado RM III, Shah N, Kar B: A successful anticoagulation protocol for the first HeartMate II implantation in the United States. Tex Heart Inst J 32: 399-401, 2005. (Pubitemid 41306805)
8. Slaughter MS, Rogers JG, Milano CA, et al; HeartMate II Investigators: Advanced heart failure treated with continuous- flow left ventricular assist device. N Engl J Med 361: 2241-2251, 2009.
9. Miller LW, Pagani FD, Russell SD, et al; HeartMate II Clinical Investigators: Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 357: 885-896, 2007. (Pubitemid 47347322)
10. Goldstein DJ, Beauford RB: Left ventricular assist devices and bleeding: Adding insult to injury. Ann Thorac Surg 75(6 Suppl): S42-S47, 2003. (Pubitemid 36677189)
11. Reilly MP, Wiegers SE, Cucchiara AJ, et al: Frequency, risk factors, and clinical outcomes of left ventricular assist device-associated ventricular thrombus. Am J Cardiol 86: 1156-1159, A10, 2000.
12. Heneghan C, Ward A, Perera R, et al; Self-Monitoring Trialist Collaboration: Self-monitoring of oral anticoagulation: Systematic review and meta-analysis of individual patient data. Lancet 379: 322-334, 2012.
13. Bloomfield HE, Krause A, Greer N, et al: Meta-analysis: Effect of patient self-testing and self-management of long-term anticoagulation on major clinical outcomes. Ann Intern Med 154: 472-482, 2011.
14. Matchar DB, Jacobson A, Dolor R, et al; THINRS Executive Committee and Site Investigators: Effect of home testing of international normalized ratio on clinical events. N Engl J Med 363: 1608-1620, 2010.
15. Meyer S, van der Meer P, Massie BM, et al: Sex-specific acute heart failure phenotypes and outcomes from PROTECT. Eur J Heart Fail 15: 1374-1381, 2013.
16. Plesch W, van den Besselaar AM: Validation of the international normalized ratio (INR) in a new point-of-care system designed for home monitoring of oral anticoagulation therapy. Int J Lab Hematol 31: 20-25, 2009.
17. Torreiro EG, Fernández EG, Rodríguez RM, López CV, Núñez JB: Comparative study of accuracy and clinical agreement of the CoaguChek XS portable device versus standard laboratory practice in unexperienced patients. Thromb Haemost 101: 969-974, 2009.
18. Rosendaal FR, Cannegieter SC, van der Meer FJ, Briët E: A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 69: 236-239, 1993. (Pubitemid 23069000)
19. Kirklin JK, Naftel DC, Stevenson LW, et al: INTERMACS database for durable devices for circulatory support: First annual report. J Heart Lung Transplant 27: 1065-1072, 2008.
20. Jennings D, McDonnell J, Schillig J: Assessment of long-term anticoagulation in patients with a continuous-flow left-ventricular assist device: A pilot study. J Thorac Cardiovasc Surg 142: e1-e2, 2011.
21. Chiquette E, Amato MG, Bussey HI: Comparison of an anticoagulation clinic with usual medical care: Anticoagulation control, patient outcomes, and health care costs. Arch Intern Med 158: 1641-1647, 1998. (Pubitemid 28371187)
22. Hall D, Buchanan J, Helms B, et al: Health care expenditures and therapeutic outcomes of a pharmacist-managed anticoagulation service versus usual medical care. Pharmacotherapy 31: 686-694, 2011.
23. Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G; American College of Chest Physicians: Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133(6 Suppl): 160S-198S, 2008. (Pubitemid 351892967)
24. Horstkotte D, Piper C, Wiemer M: Optimal frequency of patient monitoring and intensity of oral anticoagulation therapy in valvular heart disease. J Thromb Thrombolysis 5(Suppl 1): 19-24, 1998.
25. Samsa GP, Matchar DB: Relationship between test frequency and outcomes of anticoagulation: A literature review and commentary with implications for the design of randomized trials of patient self-management. J Thromb Thrombolysis 9: 283-292, 2000. (Pubitemid 30201262)
26. Rose AJ, Hylek EM, Ozonoff A, Ash AS, Reisman JI, Berlowitz DR: Patient characteristics associated with oral anticoagulation control: Results of the Veterans AffaiRs Study to Improve Anticoagulation (VARIA). J Thromb Haemost 8: 2182-2191, 2010.
27. White HD, Gruber M, Feyzi J, et al: Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: Results from SPORTIF III and V. Arch Intern Med 167: 239-245, 2007.
28. Suarez J, Patel CB, Felker GM, Becker R, Hernandez AF, Rogers JG: Mechanisms of bleeding and approach to patients with axial- flow left ventricular assist devices. Circ Heart Fail 4: 779-784, 2011.
29. Lip GYH, Andreotti F, Fauchier L, et al. Bleeding risk assessment and management in atrial fibrillation patients: A position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology working group on thrombosis. Thromb Haemost 106: 997-1011, 2011.
30. Boyle AJ, Russell SD, Teuteberg JJ, et al: Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: Analysis of outpatient anti-coagulation. J Heart Lung Transplant 28: 881-887, 2009.
31. Slaughter MS, Pagani FD, McGee EC, et al; HeartWare Bridge to Transplant ADVANCE Trial Investigators: HeartWare ventricular assist system for bridge to transplant: Combined results of the bridge to transplant and continued access protocol trial. J Heart Lung Transplant 32: 675-683, 2013.
32. Connolly SJ, Pogue J, Eikelboom J, et al; ACTIVE W Investigators: Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range. Circulation 118: 2029-2037, 2008.